Joseph Pategou

healthcare patients generics recherche clinique mhealth europe oecd legal biosimilars biosimilaire naming interchangeability biosimilar drugs humira inflectra originators strategy authorization marketing extrapolation regulations ema tec arc cro pharmaceutical competition digital intelligence business apps africa who marketing;who; ema; authorization; regulations extrapolation; originators etude clinique market innovation mheath substitution smpc; princeps remsima princeps digital strategy education data interoperability health record medications chronic illnesses decentralized electronic health record emr usa medtech insurance physicians doctors digital health ehr blockchain technology growth economy mental health duke yale harvard rwanda rhuemato remicade health smpc gastroenterology lantus population cluster mici transversality globalisation sociology organizations more cross-functional investment retail banking shareholders credit cards fee-based businesses fragmented agency interest income from corporate loans retail banking fragmented interest paid deposi corporate loans beijing private income bank banking china finance jugaad innovation jugaad schumpeterian low-cost transformation elearning school university patients; princeps pharma healthcare; apps; patients;business; intelligence mhealth; digital; digital; competition patients; patients; business; intelligence; master sante pharmaceutique biosimilar; drugs remicade; lantus; mici; gastroenterology; rhuemato digital education opportunities application challenges leadership